Expression of VEGF and microvessel density in patients with multiple myeloma: clinical and prognostic significance

By Marković Olivera   Marisavljević D.   Čemerikić V.   Vidović A.   Peruničić M.   Todorović M.   Elezović I.   Čolović M.  

Medical Oncology, Vol. 25, Iss. 4, 2008-12 ,pp. : 451-457

Humana Press, Inc

Access to resources Recommend Favorite

Therapeutic effects of autologous hematopoietic stem cell transplantation in multiple myeloma patients

By                    

Experimental and Therapeutic Medicine, Vol. 6, Iss. 4, 2013-01 ,pp. : 977-982

Spandidos Publications

Access to resources Recommend Favorite

Activity and toxicity profiles of the combinations bendamustine–lenalidomide–dexamethasone and bendamustine–bortezomib–dexamethasone for advanced stage multiple myeloma

By Mele Giuseppe   Spina Alessandro   Guaragna Gianluca   Giannotta Angela   Melpignano Angela   Quarta Gianni  

Leukemia and Lymphoma, Vol. 55, Iss. 5, 2014-05 ,pp. : 1191-1193

Informa Healthcare

Access to resources Recommend Favorite

Bisphosphonate Anticancer Activity in Multiple Myeloma

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 12, Iss. 2, 2012-01 ,pp. : 123-128

Bentham Science Publishers

Access to resources Recommend Favorite

Antitumor activity of CDA, a urinary preparation, on human multiple myeloma cell lines via the mitochondrial pathway

By          

Molecular Medicine Reports, Vol. 9, Iss. 3, 2014-01 ,pp. : 1025-1031

Spandidos Publications

Access to resources Recommend Favorite